Reversible Cognitive Impairment Associated with the Use of Dabigatran.
Department of Aged Care, The Northern Hospital, Melbourne, Australia.
Beth
B
La Brooy
Department of Haematology, The Northern Hospital, Melbourne, Australia.
Prahlad
P
Ho
Department of Aged Care, The Northern Hospital, Melbourne, Australia.
Kwang
K
Lim
D000369:Aged, 80 and over; D000991:Antithrombins / Q000009:adverse effects / Q000627:therapeutic use; D001562:Benzimidazoles / Q000009:adverse effects* / Q000627:therapeutic use; D003071:Cognition / Q000187:drug effects*; D060825:Cognitive Dysfunction / Q000139:chemically induced* / Q000503:physiopathology / Q000523:psychology; D000069604:Dabigatran; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D020127:Recovery of Function; D020521:Stroke / Q000517:prevention & control; D015091:beta-Alanine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000991:Antithrombins; D001562:Benzimidazoles; D015091:beta-Alanine; D000069604:Dabigatran